16 Jan 2021

Bulgarian Patient with Cutaneous Melanoma After Systemic Therapy with DIOVAN and EXFORGE from the Pharmaceutical Company Novartis Recognised as FIRST SEVERE ADVERSE DRUG REACTION of the Original VALSARTAN/ from Springer Nature/ Reactions Weekly:

https://link.springer.com/article/10.1007/s40267-019-00625-9